Recurrent Thrombosis in a Patient with Pseudohomozygous Activated Protein C Resistance and Homozygosity for MTHFR Gene Polymorphism C677T

Graham Standen; Colin Morse; Shazia Aslam; Ann Bowron

doi:10.1055/s-0037-1614546

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1999; 81(04): 663-664
DOI: 10.1055/s-0037-1614546

Letters to the Editor

Schattauer GmbH

Recurrent Thrombosis in a Patient with Pseudohomozygous Activated Protein C Resistance and Homozygosity for MTHFR Gene Polymorphism C677T

Authors

Graham Standen

¹From the Molecular Haematology Unit, Department of Haematology, Bristol Royal Infirmary, Bristol, UK
Colin Morse

¹From the Molecular Haematology Unit, Department of Haematology, Bristol Royal Infirmary, Bristol, UK
Shazia Aslam

¹From the Molecular Haematology Unit, Department of Haematology, Bristol Royal Infirmary, Bristol, UK
Ann Bowron

²Department of Clinical Chemistry, Bristol Royal Infirmary, Bristol, UK

Abstract

Full Text

References

References
1 Hillarp A, Dahlbäck B, Zöller B. Activated protein C resistance: from phenotype to genotype and clinical practice. Blood Rev 1995; 9: 201-12.
2 Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A. “Pseudohomozygous” activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thromb Haemost 1996; 75: 422-26.
3 Zehnder JL, Jain M. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency. Blood Coagul Fibrinolysis 1996; 7: 361-2.
4 Casterman G, Lunghi B, Missiaglia E, Bernardi F, Rodeghiero F. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V. Br J Haematol 1997; 99: 257-61.
5 Girolami A, Simioni P, Scarano L, Girolami B, Marchiori A. Haemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification. Blood Rev 1998; 12: 45-51.
6 Zighetti ML, Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Bignell M, Mannucci PM. A common mutation in the methylene-tetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q⁵⁰⁶ ). Thromb Haemost 1997 Supplement 570.
7 Morse C, Standen G. Specificity of ‘clotting’ methods for factor V Leiden. Br. J Haematol 1996; 95: 432-433.